T. Inaba
Impact in
- Pharmacology top 0.02%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Toxicology top 0.1%
- Forensic Toxicology and Drug Analysis
Papers in
- Pharmacology 57
- Pharmacogenetics and Drug Metabolism 47
- Plant-based Medicinal Research 10
- Co-authors
- W. Kalow (47 shared papers)S V Otton (14 shared papers)W Kalow (12 shared papers)Rachel F. Tyndale (10 shared papers)David J. Stewart (4 shared papers)M Jurima (9 shared papers)Frank J. Gonzalez (5 shared papers)Edward M. Sellers (5 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (22 papers)Drug Metabolism and Disposition (13 papers)Canadian Journal of Physiology and Pharmacology (10 papers)British Journal of Clinical Pharmacology (8 papers)Life Sciences (7 papers)
- Partner nations
- CanadaJapanUnited States
In The Last Decade
T. Inaba
122 papers receiving 5.2k citations
T. Inaba's Hit Papers
Peers
Comparison fields: 5 of 135
- Pharmacology 2.7k
- Toxicology 547
- Pharmacology 841
- Oncology 1.2k
- Clinical Biochemistry 319
Countries citing papers authored by T. Inaba
This map shows the geographic impact of T. Inaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Inaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Inaba more than expected).
Fields of papers citing papers by T. Inaba
This network shows the impact of papers produced by T. Inaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Inaba. The network helps show where T. Inaba may publish in the future.
Co-authors
The 25 scholars most cited alongside T. Inaba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cytochrome P-450 hPCN3, a Novel Cytochrome P-450 IIIA Gene Product That Is Differentially Expressed in Adult Human Liver Hit paper breakdown → | 1989 | 450 |
| 2 | 1979 | 246 | |
| 3 | 1978 | 216 | |
| 4 | 1977 | 206 | |
| 5 | 1996 | 200 | |
| 6 | 1987 | 198 | |
| 7 | 1984 | 179 | |
| 8 | 1985 | 168 | |
| 9 | 2002 | 158 | |
| 10 | 1994 | 148 | |
| 11 | 1989 | 143 | |
| 12 | 1997 | 139 | |
| 13 | 1991 | 130 | |
| 14 | 1991 | 110 | |
| 15 | 1985 | 102 | |
| 16 | 1991 | 96 | |
| 17 | 1991 | 93 | |
| 18 | 1993 | 88 | |
| 19 | 1989 | 77 | |
| 20 | 1999 | 75 |
About T. Inaba
T. Inaba is a scholar working on Pharmacology, Molecular Biology, Oncology, Clinical Biochemistry and Pediatrics, Perinatology and Child Health, having authored 125 papers that have together received 5.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (47 papers), Metabolism and Genetic Disorders (24 papers), Drug Transport and Resistance Mechanisms (24 papers), Analytical Chemistry and Chromatography (14 papers), Pharmacological Effects and Toxicity Studies (14 papers), Botanical Research and Chemistry (11 papers), Plant-based Medicinal Research (10 papers) and Diet and metabolism studies (10 papers). The work is most often cited by research in Pharmacology (2.7k citations), Toxicology (547 citations), Pharmacology (841 citations), Oncology (1.2k citations) and Clinical Biochemistry (319 citations). T. Inaba has collaborated with scholars based in Canada, Japan and United States. Frequent co-authors include W. Kalow, S V Otton, W Kalow, Rachel F. Tyndale, David J. Stewart, M Jurima, Frank J. Gonzalez, Edward M. Sellers, Harry V. Gelboin and Urs Meyer. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Drug Metabolism and Disposition, Canadian Journal of Physiology and Pharmacology, British Journal of Clinical Pharmacology and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.